Crystallization method of clindamycin phosphate

A technology of clindamycin phosphate and crystallization, applied in the production field of clindamycin phosphate, can solve problems such as low crystallization yield, achieve high crystallization yield, good stability, and save production time and cost. Effect

Active Publication Date: 2010-12-29
XINYU PHARM CO LTD
View PDF2 Cites 14 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The technical solution to be solved by the present invention is to provide a crystallization method of clindamycin pho

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Crystallization method of clindamycin phosphate
  • Crystallization method of clindamycin phosphate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] (1), in a 500ml spherical decolorizing tank, drop about 40g of clindamycin phosphate coarse powder (clindamycin hydrochloride obtained through esterification, hydrolysis, adsorption, and crude crystallization), add 64.8g of n-butanol and 80g of purified Water, stir and heat up to 78-80°C under water bath conditions, and keep the temperature constant for about 60 minutes;

[0022] (2), after the clindamycin phosphate coarse powder is fully dissolved, add 2g of activated carbon for decolorization, and filter while hot to remove insoluble impurities;

[0023] (3), the decolorizing liquid is pressed into a 500ml spherical crystallization tank through a fine filter, 64.8g of n-butanol is added, and when the clarified hot saturated solution of the gained is cooled to 60°C, it is vacuum concentrated, and the vacuum degree is greater than or equal to 0.09MPa. When the crystals are precipitated, stop the concentration, stir the solution at a speed of 100r / min, and keep the tempe...

Embodiment 2

[0026] (1), in a 1000ml spherical decolorization tank, drop about 80g of clindamycin phosphate coarse powder (clindamycin hydrochloride obtained through esterification, hydrolysis, adsorption, and crude crystallization), add 129.6g of n-butanol and 160g of purified Water, stir and heat up to 70-80°C in a water bath, and keep the temperature constant for about 60 minutes;

[0027] (2), after the clindamycin phosphate coarse powder is fully dissolved, add 4g of activated carbon for decolorization, and filter while hot to remove insoluble impurities;

[0028] (3) Press the decolorizing solution into a 1000ml spherical crystallization tank through a fine filter, add 129.6g of n-butanol, and when the resulting clear hot saturated solution is cooled to 60°C, slowly vacuum it to concentrate, when crystals are precipitated , stop the concentration, stir the solution at a speed of 100r / min, and keep the temperature at this temperature for 60min;

[0029] (4), then adjust the stirring ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a crystallization method of clindamycin phosphate, comprising the following steps: firstly dissolving the clindamycin phosphate in n-butanol aqueous solution; then performing crystallization after decoloration, concentration and stepped temperature reduction to below 25 DEG C, filtering, washing, and drying to obtain the finished product. The crystallization method of the clindamycin phosphate of the invention has high crystallization yield, saves the time and reduces the cost; and the clindamycin phosphate finished product has high purity, good mobility and less possibility of agglomeration.

Description

technical field [0001] The invention relates to a production method of clindamycin phosphate, in particular to a crystallization method of clindamycin phosphate. Background technique [0002] Clindamycin Phosphate is an antibiotic drug, its chemical name is: methyl 6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-7 (S)-Chloro-6,7,8-trideoxy-L-threo-a-D-galactopyranoside-2-phosphate. It has been listed in my country since 1970. Clindamycin phosphate is a chemically semi-synthesized clindamycin derivative, which has no antibacterial activity in vitro. After entering the body, it is rapidly hydrolyzed to clindamycin to exert its pharmacological effects. Its antibacterial spectrum, antibacterial activity and therapeutic effect are the same as clindamycin, but its fat solubility and permeability are better than clindamycin, and it can be administered orally, intramuscularly or intravenously. Compared with lincomycin, clindamycin phosphate has 4-8 times stronger an...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07H15/16C07H1/06
Inventor 夏守友刘伟孙冠中黄超
Owner XINYU PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap